New Expanded Indication Could Change the TAVR Narrative

Now Edwards and Medtronic’s transcatheter aortic valve replacement devices can be used in patients with low-risk for death or major complications associated with open-heart surgery. One analyst said the conversation will eventually shift toward TAVR being the “preferred treatment method.”

Concept Medical Has the ‘MagicTouch’ to Treat PAD

The Tampa, FL-based company has received breakthrough device designation from FDA for the MagicTouch PTA, a Sirolimus drug-coated balloon (DCB) catheter. The designation comes a few short days after Becton Dickinson and Co. said FDA rejected its Lutonix Paclitaxel DCB for PAD BTK.

阅读更多

MIT Model Automates AI for Medical Decision-Making

MIT computer scientists are hoping to accelerate the use of artificial intelligence to improve medical decision-making, by automating a key step that’s usually done by hand — and that’s becoming more laborious as certain datasets grow ever-larger.

Roche Expands Global Access to Viral Assays to Aid Eradication Efforts

Access to diagnostic assays is key to achievement of the World Health Organization’s infectious disease elimination goals.

How 2019 Will Define TAVR for Years to Come

New approvals; product withdrawals; and a high profile procedure could easily cause 2019 to be one of the most memorable years for TAVR.

May the Best Spine Robot Win

Dave Demski, CEO of Globus Medical, said it is taking longer to sell robotic systems due to increasing competitive marketing initiatives. Hospital executives are taking longer to make the purchasing decision as they evaluate potential alternatives, he said.

What Could Blockchain Technologies Mean for the Medical Device Industry?

Blockchain offers a number of potential use cases, but there are some challenges to overcome.

How to Attract AI Talent for Your Medical Device

Competition for AI talent is white hot. So how can medtech companies differentiate themselves to snag the best AI engineers?

The Robots Are Coming, Are You Ready?

The surgical robotics landscape is moving at a lightening pace, with more and more entrants each year. What will this mean for medtech?

Glaukos’ iStent Has Strong Showing in 5-Year Data

Results from the prospective, randomized, controlled, multi-surgeon clinical trial were published in Ophthalmology Glaucoma.